@article{9f469a1ad6a74630beb10f37bbaad2c9,
title = "Introduction",
author = "Michael Schatz and Kazzi, {Amin Antoine Nabih} and Barry Brenner and Camargo, {Carlos A.} and Thomas Corbridge and Krishnan, {Jerry A.} and Richard Nowak and Gary Rachelefsky",
note = "Funding Information: Disclosure of potential conflict of interest: M. Schatz has been a consultant for GlaxoSmithKline and has received research support from Aerocrine, Genentech, GlaxoSmithKline and Merck. A. A. N. Kazzi has declared that he had no conflict of interest. B. Brenner has declared that he had no conflict of interest. C. A. Camargo Jr has been a consultant, speaker, or advisory board member for AstraZeneca, Critical Therapeutics, Dey, Genentech, GlaxoSmithKline, Merck, Novartis, and Schering-Plough and has received research support from the National Institutes of Health, AstraZeneca, Critical Therapeutics, GlaxoSmithKline, Merck, Novartis, and Respironics. T. Corbridge is on the speakers' bureau for GlaxoSmithKline. J. A. Krishnan has declared that he had no conflict of interest. R. Nowak has declared that he had no conflict of interest. G. Rachelefsky has been a speaker or advisory board member for AstraZeneca, Schering-Plough, CSL Behring, Merck, and Sanofi Aventis and has provided legal consultation or expert witness testimony on the topic of environmental injuries, mostly mold-related. Copyright: Copyright 2009 Elsevier B.V., All rights reserved.",
year = "2009",
month = aug,
doi = "10.1016/j.jemermed.2009.06.104",
language = "English (US)",
volume = "37",
pages = "S1--S5",
journal = "Journal of Emergency Medicine",
issn = "0736-4679",
publisher = "Elsevier USA",
number = "2 SUPPL.",
}